Home > Resources > Infographics > Impedance Based Microfluidic Device for Measuring Drug Response of Cancer Cells

Impedance Based Microfluidic Device for Measuring Drug Response of Cancer Cells

November 11, 2018

Dielectrophoresis (DEP) is the motion of polarizable particles that are suspended in an ionic solution and subjected to a spatially non-uniform electric field. Polarizability of a particle relative to the suspending medium determines the basic direction of DEP force (positive/negative DEP), which also strongly depends on the frequency of the applied electric field

I'm For Real

Enter your details once to access all our information and resources

 

Spotlight

PT Anugerah Pharmindo Lestari

PT Anugerah Pharmindo Lestari (APL) has been successfully serving the Indonesian healthcare market since 1985. We make available high quality healthcare products for patients and consumers across the complex geography and multi-channel environment of Indonesia. In our line of business, customer coverage, reach and service levels are the most important and necessary core competencies of our organization. Our wide distribution network meets the needs of the market in all of the 34 provinces. We operate 33 pharma-grade warehouses of highest international quality standards in 28 cities across Indonesia. The APL sales forces cover a total of 434 cities with a directly served customer base of 28,000+ accounts. 100,000 general trade accounts are served through a customized regional sub-distribution network.

Other Infographics
news image

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.

Read More
news image

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Read More
news image

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Read More
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

Pharma Technology Focus

Infographic | June 3, 2022

Pharma Technology Focus is free to read on all devices.

Read More

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.

Read More

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Read More

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Read More

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More

Pharma Technology Focus

Infographic | June 3, 2022

Pharma Technology Focus is free to read on all devices.

Read More
More Infographics

Spotlight

PT Anugerah Pharmindo Lestari

PT Anugerah Pharmindo Lestari (APL) has been successfully serving the Indonesian healthcare market since 1985. We make available high quality healthcare products for patients and consumers across the complex geography and multi-channel environment of Indonesia. In our line of business, customer coverage, reach and service levels are the most important and necessary core competencies of our organization. Our wide distribution network meets the needs of the market in all of the 34 provinces. We operate 33 pharma-grade warehouses of highest international quality standards in 28 cities across Indonesia. The APL sales forces cover a total of 434 cities with a directly served customer base of 28,000+ accounts. 100,000 general trade accounts are served through a customized regional sub-distribution network.

Events